new YORK (Reuters Health) – young to adults
placed les a stent in coronary arteries before the
40 years obtained excellent results both in the short and
long-term, and Italian experts who published the finding
believe that such devices should be the treatment of
choice in this age group.
“The stent placement in patients 40 years or less is
“
very rare, only 2 to 3 per cent of all the
“
procedures performed in our area”, told Reuters
Health Dr. Emanuele Meliga of the Mauriziano Hospital in
Turin.
People young people with coronary artery disease (EAC)
requiring intervention usually have risk factors
cardiovascular multiple, such as hypertension, Dyslipidemia,
diabetes, a family of EAC and, above all, history
smoking, said the expert.
In a report published in the American Journal of Cardiology,
the doctor Meliga and his colleagues noticed that the EAC in the
younger patients with great frequency is not because not
recognized.
About 60 percent of the patients in this study,
for example, had high blood pressure or high cholesterol, but to the
upon entering the hospital for the procedure of
stent placement, less than 5 per cent was receiving
reducing agents of antihypertensive or lipid.
The results were obtained after analyzing records of 214
consecutive patients (an 88 percent male) that is
underwent coronary angiography with stent implantation in
one of five centers of tertiary care between 2005 and the
2010.
The average age was 36 years, 77 percent were
active smoking and the most common clinical presentation was the
myocardial infarction with ST segment elevation (a 57 by
cent).
Throughout the cohort, patients received a total
272 stent: sending simple and 118 metallic 154 of
medication.
The rate of cerebrovascular and heart episodes
important during the hospital stay was the 2.3 by
cent. There were no deaths in the hospital.
With a median follow-up of 757 days, the mortality rate
general was 0.9 per cent and the incidence of heart attack of
infarction was the 3.7 percent, while to a 12.6 by
% of patients required a new procedure of
revascularization.
In contrast to the lack of treatment marked on the
patients who participated in the study prior to the
hospitalization, medical treatment later played “a role
“
significant in the excellent clinical outcomes reported
“
in the present study”, wrote the authors.
At the time of discharge, patients were given aspirin and
clopidogrel, 90 per cent are prescribed statins and a
70 per cent received prescription of beta-blockers and
the angiotensin-converting enzyme inhibitors.
All patients are prescribed at least one drug
antihypertensive.
Source: American Journal of Cardiology, online March 22,
2012
